Related Experiment Video
Updated: Jan 12, 2026

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
Radiotherapy Planning for Nasopharyngeal Carcinoma After Induction Chemotherapy: A Systematic Review to Inform
Omar Nouri1, Ryan Anthony Agas2,3, Lester Bryan Co4
1Department of Radiation Oncology, University of Sfax - Faculty of Medicine, EPS Habib Bourguiba, Sfax, Tunisia.
Purpose:
Induction chemotherapy (ICT) followed by concurrent chemoradiotherapy is a standard of care in locoregionally advanced nasopharyngeal carcinoma (LA-NPC). However, there is a lack of consensus on appropriate radiotherapy (RT) target volumes and prescriptions after ICT. We systematically reviewed the literature to inform a planned international consensus guideline development.
Methods And Materials:
A scoping review was done to define the areas of significant practice differences, followed by a systematic review. The reviews were conducted by a Steering Committee (SC) and an Evidence Review Committee (ERC) consisting of radiation oncologists with expertise in treating NPC.
Results:
The scoping review revealed significant practice differences on (1) optimal timing for post-ICT RT, (2) ideal imaging modalities for RT target delineation, (3) RT dose prescription and fractionation, and (4) RT target volume delineation. The systematic review found no specific recommendations on optimal timing for post-ICT RT and optimal imaging modalities. Regarding dose prescription, current guidelines advocate including two or three dose levels. Differences in post-induction target volume delineation were found. The data show that volume reduction may be possible without compromising oncologic outcomes and may improve quality of life.
Conclusion:
There is a lack of evidence and guidelines on post-ICT RT timing and optimal imaging modalities. Guidelines on post-ICT target volumes and dose levels differ significantly; published evidence from clinical trials is limited. Considering this lack of consensus after ICT in LA-NPC, international consensus guidelines among experts from endemic regions are needed and may help harmonize practices.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

